Understanding the mechanisms of resistance to azole antifungals in Candida species
JAC-Antimicrobial Resistance · 29.04.2025 · 7 (3)
DOI: 10.1093/jacamr/dlaf106 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 23.06.2025. Verfasst von Yunxiao Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Cancer and Pharmaceutical Science, King's College London, London SE1 9NH, UK. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKHSA’s Open Innovation, Medical Research Council, King’s-China Scholarship Council.
Abstract (Originalsprache)
Cases of Candida infection have been on the rise in recent years. A comprehensive and clear understanding of the mechanisms of antifungal resistance is fundamental for developing novel therapies to address the current and emerging threat of fungal diseases. Certain Candida species can cause superficial or invasive infections in immunocompromised hosts, and invasive Candida infections are major contributors to infectious disease deaths. As fungi are eukaryotes like humans, there are only a limited number of unique molecular targets available for antifungal drug development. Until recently, there have only been four primary classes of antifungals used to treat systemic fungal infections. Among these, azole antifungals are globally used because they are both inexpensive and effective. Due to various factors, resistance to antifungal drugs—especially azole antifungals—has developed in many Candida species, posing a significant public health threat. This review discusses the known mechanisms of azole antifungal resistance in Candida albicans, Candida auris, Nakaseomyces glabrata, Candida tropicalis, Candida parapsilosis and explores strategies to overcome the resistance problem.
Autor:innen und Institutionen
- School of Cancer and Pharmaceutical Science, King's College London, London SE1 9NH, UK.
- Antimicrobial Discovery Development and Diagnostics Team, UK Health Security Agency, Porton Down SP4 0JG, UK.
- Klura Labs, The Epicentre, Haverhill Research Park, Enterprise Wy, Haverhill CB9 7LR, UK.
ORCID-Profile: Khondaker Miraz Rahman
Förderung
- UKHSA’s Open Innovation
- Medical Research Council
- King’s-China Scholarship Council
- UKHSA
- Department of Health and Social Care
Zitieren
APA
Li, Y., Hind, C., Furner-Pardoe, J., Sutton, J. M., & Rahman, K. M. (2025). Understanding the mechanisms of resistance to azole antifungals in Candida species. JAC-Antimicrobial Resistance, 7(3). https://doi.org/10.1093/jacamr/dlaf106
Vancouver
Li Y, Hind C, Furner-Pardoe J, Sutton JM, Rahman KM. Understanding the mechanisms of resistance to azole antifungals in Candida species. JAC-Antimicrobial Resistance. 2025;7(3). doi:10.1093/jacamr/dlaf106
BibTeX
@article{Li2025,
author = {Li, Yunxiao and Hind, Charlotte and Furner-Pardoe, Jessica and Sutton, J Mark and Rahman, Khondaker Miraz},
title = {Understanding the mechanisms of resistance to azole antifungals in Candida species},
journal = {JAC-Antimicrobial Resistance},
year = {2025},
volume = {7},
number = {3},
doi = {10.1093/jacamr/dlaf106}
}
EUVIMED